Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

The US Food and Drug Administration (FDA) is taking action to mitigate shortages of Mylan’s EpiPen (epinephrine), an auto-injector-based epinephrine product for treating adverse allergic reactions, by extending the expiration date of specific lots...

The US Department of Justice (DOJ) and the US Drug Enforcement Administration (DEA) have proposed a reduction for controlled substances that may be manufactured in the US in 2019. The proposal decreases manufacturing quotas for six opioids for 2019...

Astellas Pharma has acquired Quethera, a Cambridge, UK-headquartered gene-therapy company focused on developing treatments for ocular disorders, such as glaucoma, in a deal worth up to £85 million ($108 million). Through this transaction, Astellas...

Perrigo has announced plans to separate the company's prescription pharmaceuticals (Rx) business following a strategic portfolio review. The move follows continuing weak performance in the company’s Rx business, which accounted for approximately...

ANI Pharmaceuticals, a Baudette, Minnesota-headquartered specialty pharmaceutical company, has acquired WellSpring Pharma Services, an Oakville, Canada-headquartered contract development and manufacturing organization (CDMO) of drug products, for...